Company / PP&E (Net)
ENvue Medical, Inc. PP&E (Net) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$119.0K
FY2025
5-year range
$5.0K / $119.0K
FY2021-FY2025
Trend
+1222.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
PP&E (Net) changed +1222% YoY in FY2025, a notable deviation from the 9-year average annual change of +140%.
Based on SEC 10-K filings.
$119,000 in FY2025 with a 5-year CAGR of +97.1%.
Improved from $7,000 to $119,000 over the past 2 years.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- +157.1%
- 5-Year CAGR
- +97.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +97.1%, indicating consistent growth.
- In FY2025, pp&e (net) increased 1222.2% year-over-year.
- Lowest pp&e (net) in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -0.19 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $119.0K | +1222.2% |
| FY2024 | $9.0K | +28.6% |
| FY2023 | $7.0K | +0.0% |
| FY2022 | $7.0K | +40.0% |
| FY2021 | $5.0K | +25.0% |
| FY2020 | $4.0K | +0.0% |
| FY2019 | $4.0K | -50.0% |
| FY2018 | $8.0K | +33.3% |
| FY2017 | $6.0K | -40.0% |
| FY2016 | $10.0K | +0.0% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026